Neuroone Medical Technologies Corp

NASDAQ NMTC
$0.79 0.06 8.47%
Today share price
USA
Sector: Healthcare Industry: Medical Devices
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 21.25 %
Market cap Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.
26.45M
EV Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
25.24M
Beta Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
-
Shares Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
31.11M
YTD Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-4.01 %

Upcoming events Neuroone Medical Technologies Corp

All events
No upcoming events scheduled

Stock chart Neuroone Medical Technologies Corp

Stock analysis Neuroone Medical Technologies Corp

Indicator Company Industry
P/E (LTM) Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
-4.01 -2.59
P/BV (LTM) Shows the ratio of the market price of the share to the current book value.
26.89 1.36
EV/EBITDA (LTM) Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
-4.19 -2.52
Net Debt/EBITDA (LTM) A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
0.20 0.34
ROE (LTM) Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
-586.52 -40.86

Price change Neuroone Medical Technologies Corp per year

0.43$ 1.22$
Min Max

Summary analysis Neuroone Medical Technologies Corp

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Neuroone Medical Technologies Corp

Revenue and net income Neuroone Medical Technologies Corp

All parameters

About company Neuroone Medical Technologies Corp

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, radio frequency and brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company also focuses on applications of its technology associated with artificial intelligence. It has partnership with RBC Medical Innovations to develop a radio frequency ablation generator. NeuroOne Medical Technologies Corporation is based in Eden Prairie, Minnesota.
Address:
7599 Anagram Drive, Eden Prairie, MN, United States, 55344
Company name: Neuroone Medical Technologies Corp
Issuer ticker: NMTC
ISIN: US64130M2098
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2017-09-18
Sector: Healthcare
Industry: Medical Devices
Site: https://nmtc1.com